Sylvester Comments on FDA Report about CBD

06 March 2020 Food Navigator-USA News

Special Counsel Brian Sylvester was quoted in a Food Navigator-USA article, “FDA report on CBD seen as ‘disappointing’ recap of status quo,” about a report to Congress on CBD by FDA Commissioner Dr. Stephen Hahn.


Sylvester said the report suggests that FDA may be more focused on dietary supplements as a lawful regulatory pathway. “With the release of FDA’s report, we now know that FDA currently views dietary supplements as a potentially more viable pathway than food,” he said.

Related Services


What’s Next for Blockchain and Crypto?
01 December 2022
Innovative Technology Insights
Case Law Update: Disputes Relating to Supply Chain Disruptions Hit the Courts
01 December 2022
Manufacturing Industry Advisor
Foley Partner André Thiollier Moderates Global Venture Market Session at BayBrazil Conference
01 December 2022
Foley Ignite
Podcast Episode 96: Eric Williams, Associate
01 December 2022
Foley Career Perspectives
What You Should Know About Payor/Provider Convergence
25-26 January 2023
Los Angeles, CA
ATA EDGE2022 Policy Conference | American Telemedicine Association
7-9 December 2022
Washington, D.C.
CLE Weeks
5-16 December 2022
Milwaukee, WI
Foley Sponsors Ernst & Young Entrepreneur of the Year® Program
1 December 2021 - 30 November 2022
Michigan and Northwest Ohio Region